Extracorporeal Shockwave Myocardial Revascularization (ESMR)
Malaysian Health Technology Assessment (MaHTAS)
Record ID 32016000293
English
Authors' objectives:
To review evidence on the effectiveness, safety and costeffectiveness of using ESMR therapy for treatment coronary arterial disease patients.
Authors' recommendations:
Extracorporeal Shock wave Myocardial Revascularization therapy (ESMR) has potential as an effective, non-invasive intervention in the treatment of patients with CAD. There was one retrievable study reporting that, this ESMR device was well tolerated. Only minimal discomfort was reported during the treatment procedure. However, more clinical studies such as Randomised Controlled Trial are needed to provide high quality evidence to show its effectiveness and safety profile in terms of relevant outcomes measurement and identification of complications.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.moh.gov.my/index.php/database_stores/store_view_page/30/253
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Malaysia
MeSH Terms
- Humans
- High-Energy Shock Waves
- Myocardial Revascularization
Contact
Organisation Name:
Malaysian Health Technology Assessment
Contact Address:
Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229
Contact Name:
htamalaysia@moh.gov.my
Contact Email:
htamalaysia@moh.gov.my
Copyright:
Malaysian Health Technology Assessment (MaHTAS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.